- Home
- ADN vs BIAF Comparison
ADN vs BIAF Comparison
Compare ADN & BIAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADN
- BIAF
- Stock Information
- Founded
- ADN 2006
- BIAF 2014
- Country
- ADN United States
- BIAF United States
- Employees
- ADN N/A
- BIAF N/A
- Industry
- ADN Power Generation
- BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- ADN Utilities
- BIAF Health Care
- Exchange
- ADN Nasdaq
- BIAF Nasdaq
- Market Cap
- ADN 11.3M
- BIAF 12.2M
- IPO Year
- ADN N/A
- BIAF 2022
- Fundamental
- Price
- ADN $3.10
- BIAF $0.70
- Analyst Decision
- ADN
- BIAF Hold
- Analyst Count
- ADN 0
- BIAF 1
- Target Price
- ADN N/A
- BIAF N/A
- AVG Volume (30 Days)
- ADN 18.0K
- BIAF 28.4M
- Earning Date
- ADN 12-27-2024
- BIAF 05-14-2025
- Dividend Yield
- ADN N/A
- BIAF N/A
- EPS Growth
- ADN N/A
- BIAF N/A
- EPS
- ADN N/A
- BIAF N/A
- Revenue
- ADN $8,157,000.00
- BIAF $9,362,022.00
- Revenue This Year
- ADN $2,232.99
- BIAF $25.19
- Revenue Next Year
- ADN $91.56
- BIAF $20.00
- P/E Ratio
- ADN N/A
- BIAF N/A
- Revenue Growth
- ADN 274.35
- BIAF 269.68
- 52 Week Low
- ADN $1.71
- BIAF $0.24
- 52 Week High
- ADN $8.79
- BIAF $3.16
- Technical
- Relative Strength Index (RSI)
- ADN 26.92
- BIAF 58.28
- Support Level
- ADN $3.45
- BIAF $0.24
- Resistance Level
- ADN $4.82
- BIAF $1.55
- Average True Range (ATR)
- ADN 0.46
- BIAF 0.13
- MACD
- ADN -0.19
- BIAF 0.08
- Stochastic Oscillator
- ADN 1.89
- BIAF 35.17
About ADN Advent Technologies Holdings Inc.
Advent Technologies Holdings Inc is an innovation-driven company in the fuel cell and hydrogen technology space. The company develops, manufactures, and assembles complete fuel cell systems and the critical components that determine the performance of hydrogen fuel cells and other energy systems. It serves automotive; aviation and power generation industries. It generates revenue from the sale of fuel cell systems and the sale of MEAs, membranes, and electrodes for specific applications in the fuel cell and energy storage (flow battery) markets.
About BIAF bioAffinity Technologies Inc.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.